SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-010026
Filing Date
2016-11-14
Accepted
2016-11-14 14:40:26
Documents
52
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q zyne-20160930x10q.htm 10-Q 882471
2 EX-10.1 zyne-20160930ex101e77c85.htm EX-10.1 73918
3 EX-10.2 zyne-20160930ex10291f843.htm EX-10.2 125947
4 EX-31.1 zyne-20160930ex311b1ea8b.htm EX-31.1 12253
5 EX-31.2 zyne-20160930ex3129916a3.htm EX-31.2 12133
6 EX-32.1 zyne-20160930ex3212bbc7e.htm EX-32.1 6164
7 EX-32.2 zyne-20160930ex322892e36.htm EX-32.2 6160
8 GRAPHIC zyne20160930x10q001.jpg GRAPHIC 59133
  Complete submission text file 0001558370-16-010026.txt   3808462

Data Files

Seq Description Document Type Size
9 EX-101.INS zyne-20160930.xml EX-101.INS 717997
10 EX-101.SCH zyne-20160930.xsd EX-101.SCH 26564
11 EX-101.CAL zyne-20160930_cal.xml EX-101.CAL 30277
12 EX-101.DEF zyne-20160930_def.xml EX-101.DEF 94841
13 EX-101.LAB zyne-20160930_lab.xml EX-101.LAB 241043
14 EX-101.PRE zyne-20160930_pre.xml EX-101.PRE 196351
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37526 | Film No.: 161993809
SIC: 2834 Pharmaceutical Preparations